O	0	9	Combining
B-intervention	10	16	Manual
I-intervention	17	22	Lymph
I-intervention	23	31	Drainage
I-intervention	32	36	with
I-intervention	37	45	Physical
I-intervention	46	54	Exercise
O	55	60	after
O	61	69	Modified
O	70	77	Radical
O	78	88	Mastectomy
O	89	100	Effectively
O	101	109	Prevents
B-condition	110	115	Upper
I-condition	116	120	Limb
I-condition	121	131	Lymphedema
O	131	132	.

O	133	138	Upper
O	139	143	limb
O	144	154	lymphedema
O	155	157	is
O	158	159	a
O	160	166	common
O	167	179	complication
O	180	185	after
O	186	193	radical
O	194	204	mastectomy
O	205	207	in
O	208	216	patients
O	217	221	with
O	222	228	breast
O	229	235	cancer
O	235	236	.

O	237	239	In
O	240	244	this
O	245	250	study
O	250	251	,
O	252	254	we
O	255	263	examined
O	264	267	the
O	268	276	efficacy
O	277	279	of
O	280	284	self
O	284	285	-
O	285	291	manual
O	292	297	lymph
O	298	306	drainage
O	307	308	(
O	308	311	MLD
O	311	312	)
O	313	318	after
O	319	327	modified
O	328	335	radical
O	336	346	mastectomy
O	347	350	for
O	351	354	the
O	355	365	prevention
O	366	368	of
O	369	374	upper
O	375	379	limb
O	380	390	lymphedema
O	390	391	,
O	392	396	scar
O	397	406	formation
O	406	407	,
O	408	410	or
O	411	419	shoulder
O	420	425	joint
O	426	437	dysfunction
O	438	440	in
O	441	447	breast
O	448	454	cancer
O	455	463	patients
O	463	464	.

B-eligibility	465	471	Breast
I-eligibility	472	478	cancer
I-eligibility	479	487	patients
I-eligibility	488	497	scheduled
I-eligibility	498	501	for
I-eligibility	502	510	modified
I-eligibility	511	518	radical
I-eligibility	519	529	mastectomy
O	530	534	were
O	535	543	randomly
O	544	555	apportioned
O	556	558	to
O	559	566	undergo
B-control	567	575	physical
I-control	576	584	exercise
I-control	585	589	only
O	590	591	(
O	591	593	PE
O	594	599	group
O	599	600	,
O	601	604	the
O	605	612	control
O	612	613	;
O	614	615	n
O	616	617	=
B-control-participants	618	621	500
O	621	622	)
O	623	625	or
O	626	630	self
O	630	631	-
O	631	634	MLD
O	635	637	as
O	638	642	well
O	643	645	as
O	646	654	exercise
O	655	656	(
O	656	659	MLD
O	660	665	group
O	665	666	;
O	667	668	n
O	669	670	=
B-intervention-participants	671	674	500
O	674	675	)
O	676	681	after
O	682	689	surgery
O	689	690	.

O	691	693	In
O	694	697	the
O	698	700	PE
O	701	706	group
O	706	707	,
O	708	716	patients
O	717	724	started
O	725	727	to
O	728	737	undertake
O	738	746	remedial
O	747	756	exercises
O	757	760	and
O	761	772	progressive
O	773	779	weight
O	780	788	training
O	789	794	after
O	795	803	recovery
O	804	808	from
O	809	819	anesthesia
O	819	820	.

O	821	823	In
O	824	827	the
O	828	831	MLD
O	832	837	group
O	837	838	,
O	839	841	in
O	842	850	addition
O	851	853	to
O	854	863	receiving
O	864	867	the
O	868	872	same
O	873	883	treatments
O	884	886	as
O	887	889	in
O	890	893	the
O	894	896	PE
O	897	902	group
O	902	903	,
O	904	907	the
O	908	916	patients
O	917	921	were
O	922	929	trained
O	930	932	to
O	933	940	perform
O	941	945	self
O	945	946	-
O	946	949	MLD
O	950	952	on
O	953	956	the
O	957	965	surgical
O	966	974	incision
O	975	978	for
O	979	981	10
O	982	985	min
O	985	986	/
O	986	993	session
O	993	994	,
O	995	996	3
O	997	1005	sessions
O	1005	1006	/
O	1006	1009	day
O	1009	1010	,
O	1011	1020	beginning
O	1021	1026	after
O	1027	1033	suture
O	1034	1041	removal
O	1042	1045	and
O	1046	1054	incision
O	1055	1062	closure
O	1063	1064	(
O	1064	1066	10
O	1067	1069	to
O	1070	1072	30
O	1073	1077	days
O	1078	1083	after
O	1084	1087	the
O	1088	1095	surgery
O	1095	1096	)
O	1096	1097	.

O	1098	1102	Scar
O	1103	1112	formation
O	1113	1116	was
O	1117	1126	evaluated
O	1127	1129	at
O	1130	1133	one
O	1134	1138	week
O	1138	1139	,
O	1140	1143	and
O	1144	1145	1
O	1145	1146	,
O	1147	1148	3
O	1148	1149	,
O	1150	1151	6
O	1151	1152	,
O	1153	1156	and
O	1157	1159	12
O	1160	1166	months
O	1167	1172	after
O	1173	1176	the
O	1177	1184	surgery
O	1184	1185	,
O	1186	1198	respectively
O	1198	1199	.

O	1200	1205	Upper
O	1206	1210	limb
O	1211	1224	circumference
O	1225	1228	and
O	1229	1237	shoulder
O	1238	1247	abduction
O	1248	1252	were
O	1253	1261	measured
O	1262	1264	24
O	1265	1266	h
O	1267	1273	before
O	1274	1281	surgery
O	1281	1282	,
O	1283	1286	and
O	1287	1289	at
O	1290	1293	one
O	1294	1298	week
O	1298	1299	,
O	1300	1303	and
O	1304	1305	1
O	1305	1306	,
O	1307	1308	3
O	1308	1309	,
O	1310	1311	6
O	1312	1315	and
O	1316	1318	12
O	1319	1325	months
O	1326	1331	after
O	1332	1335	the
O	1336	1343	surgery
O	1343	1344	.

O	1345	1353	Compared
O	1354	1356	to
O	1357	1362	those
O	1363	1365	in
O	1366	1369	the
O	1370	1372	PE
O	1373	1378	group
O	1378	1379	,
O	1380	1388	patients
O	1389	1391	in
O	1392	1395	MLD
O	1396	1401	group
O	1402	1413	experienced
O	1414	1425	significant
O	1426	1438	improvements
O	1439	1441	in
B-outcome	1442	1446	scar
I-outcome	1447	1458	contracture
O	1458	1459	,
B-outcome	1460	1468	shoulder
I-outcome	1469	1478	abduction
O	1478	1479	,
O	1480	1483	and
B-outcome	1484	1489	upper
I-outcome	1490	1494	limb
I-outcome	1495	1508	circumference
O	1508	1509	.

O	1510	1514	Self
O	1514	1515	-
O	1515	1518	MLD
O	1518	1519	,
O	1520	1522	in
O	1523	1534	combination
O	1535	1539	with
O	1540	1548	physical
O	1549	1557	exercise
O	1557	1558	,
O	1559	1561	is
O	1562	1572	beneficial
O	1573	1576	for
O	1577	1583	breast
O	1584	1590	cancer
O	1591	1599	patients
O	1600	1602	in
O	1603	1613	preventing
O	1614	1628	postmastectomy
O	1629	1633	scar
O	1634	1643	formation
O	1643	1644	,
O	1645	1650	upper
O	1651	1655	limb
O	1656	1666	lymphedema
O	1666	1667	,
O	1668	1671	and
O	1672	1680	shoulder
O	1681	1686	joint
O	1687	1698	dysfunction
O	1698	1699	.
